Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

RYAN vs ERIE: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ERIE Captures Overall Composite Edge (47.8 HOLD vs 40.7 SELL), While RYAN Leads 5–1 on Growth & Valuation Pillars

ERIE Overall Winner 6-Pillar Tally: RYAN 5 – 1 ERIE Matrix Metrics: RYAN 4 – 6 ERIE

As of Nov 16, 2026, Erie Indemnity Co (ERIE) captures the overall head-to-head institutional edge over Ryan Specialty Holdings, Inc. (RYAN) on higher Unified Composite conviction (47.8/100 HOLD vs. 40.7/100 SELL) after splitting the core matrix 6–4 (led by Options & Positioning), while RYAN wins 5–1 across the 6-pillar growth and valuation breakdown. RYAN trades at $47.86 (19.7x Forward P/E, 19.8% operating margin) versus ERIE at $275.90 (20.7x Forward P/E, 18.3% operating margin).

  • Growth vs. Quality Trade-Off: ERIE earns the overall head-to-head edge with a stronger Unified Composite Score (47.8/100 HOLD vs. RYAN 40.7/100 SELL) and -0.51β · 38% Vol risk profile, whereas RYAN leads top-line expansion (+4.8% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About RYAN vs ERIE
RYAN NYSE
Ryan Specialty Holdings, Inc.
Insurance Agents, Brokers & Service
$47.86
+2.07% 1D
Market Cap $11.9B
TTM Revenue $6.20B
Forward P/E 19.7x
Beta / 30D Vol -0.32β · 39% Vol
Unified Composite Score
40.7 / 100 SELL
Tech 22.0 Fund 38.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.6% over 20 days), RSI 67
RSI-14: 66.9 · SMA20: $45.34 · SMA50: $41.30
ERIE NASDAQ Head-to-Head Winner
Erie Indemnity Co
Insurance Agents, Brokers & Service
$275.90
+0.43% 1D
Market Cap $14.4B
TTM Revenue $4.12B
Forward P/E 20.7x
Beta / 30D Vol -0.51β · 38% Vol
Unified Composite Score
47.8 / 100 HOLD
Tech 28.0 Fund 46.0 Flow 65.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (0.9% over 20 days), RSI 64
RSI-14: 63.6 · SMA20: $263.74 · SMA50: $244.94

6-Pillar Scorecard Institutional Category Breakdown (RYAN 5 – 1 ERIE)

Columns: Metric · RYAN · ERIE
1. Valuation Multiples RYAN
Forward P/E 19.7x 20.7x
Trailing P/E 58.6x 24.9x
PEG Ratio N/M 2.67x
EV / Revenue 1.9x 3.5x
2. Growth & Scale RYAN
Revenue Growth (YoY) +4.8% +0.3%
Earnings Growth (YoY) +43.1% -0.5%
TTM Revenue (USD) $6.20B $4.12B
Market Cap $11.9B $14.4B
3. Profitability & Quality RYAN
Gross Margin 41.1% 17.9%
Operating Margin 19.8% 18.3%
Net Profit Margin 3.3% 14.0%
Return on Equity (ROE) 25.1% 23.7%
4. Balance Sheet & Cash Flow RYAN
Cash Generation (TTM) $1.77B EBITDA $554M
Cash Flow Margin 28.5% EBITDA Mgn 13.4%
Net Cash / Leverage $3.71 Book/Sh · 25.1% ROE $48.82 Book/Sh · 23.7% ROE
Dividend Yield 1.11% 2.17%
5. Options & Positioning ERIE
Options Structure Phase UNCLASSIFIED SURGE
Current IV / %ile 29.7% (12th %ile) 38.9% (6th %ile)
Put/Call OI Skew N/A 0.01x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Markup
6. R&D & Supply-Chain Moat RYAN
OpEx & R&D Intensity 21.3% of Rev ($1.32B) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Insurance Brokers Operator Insurance Brokers Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: RYAN (4) vs ERIE (6)
Institutional Metric RYAN ERIE Criterion Row Edge
Market Capitalization
Scale
$11.9B $14.4B Larger Scale ERIE
Trailing P/E Ratio
Valuation
58.6x 24.9x Lower Multiple ERIE
Forward P/E Ratio
Valuation
19.7x 20.7x Lower Multiple RYAN
Revenue Growth (YoY)
Growth
+4.8% +0.3% Higher Growth RYAN
Operating Margin (TTM)
Profitability
19.8% 18.3% Higher Margin RYAN
Net Profit Margin
Profitability
3.3% 14.0% Higher Margin ERIE
Return on Equity (ROE)
Capital Efficiency
25.1% 23.7% Higher ROE RYAN
52-Week Range Position
Momentum
63% ($29–$59) 74% ($205–$302) Stronger Trend ERIE
Beta / 30D Volatility
Risk Regime
-0.32β · 39% Vol -0.51β · 38% Vol Lower Realized Risk ERIE
Unified Institutional Score
Composite Signal
40.7 / 100 (SELL) 47.8 / 100 (HOLD) Higher Composite ERIE
Trailing 12M Revenue (USD)
Operating Scale
$6.20B $4.12B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
41.1% 17.9% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 1.9x EV/Rev 2.67x PEG · 3.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$1.77B EBITDA ($3.71 Book/Sh · 25.1% ROE) $554M ($48.82 Book/Sh · 23.7% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon RYAN +4.24 pp
RYAN: +17.45% · ERIE: +13.21%
3M Horizon RYAN +8.67 pp
RYAN: +16.05% · ERIE: +7.38%
6M Horizon RYAN +17.58 pp
RYAN: +42.14% · ERIE: +24.56%
1Y Horizon ERIE +11.9 pp
RYAN: -15.83% · ERIE: -3.93%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RYAN vs ERIE. Trailing 12-month operating profitability (RYAN 19.8% vs ERIE 18.3%) and valuation multiples (RYAN 19.7x vs ERIE 20.7x Forward P/E) are benchmarked directly in Pillar 4 below.

RYAN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$6.20B
Gross Margin41.1%
Op. Margin19.8%
ROE / Fwd P/E25.1% · 19.7x
ERIE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$4.12B
Gross Margin17.9%
Op. Margin18.3%
ROE / Fwd P/E23.7% · 20.7x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
RYAN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 29.7%
IV Percentile 12th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact RYAN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ERIE SURGE
7d in phase · OBV NEUTRAL
Current IV 38.9%
IV Percentile 6th %ile
Put/Call OI Skew 0.01x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ERIE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
RYAN Moat Profile Scale & Operating Efficiency Moat
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $11.9B market capitalization and 19.8% operating margin.
OpEx & R&D Reinvestment 21.3% of Rev ($1.32B)
90D Engineering Disclosures 0 Published
ERIE Moat Profile Scale & Operating Efficiency Moat
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $14.4B market capitalization and 18.3% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ RYAN vs ERIE Key Questions & Quantitative Answers

As of Nov 16, 2026, Erie Indemnity Co (ERIE) captures the overall head-to-head institutional edge over Ryan Specialty Holdings, Inc. (RYAN) on higher Unified Composite conviction (47.8/100 HOLD vs. 40.7/100 SELL) after splitting the core matrix 6–4 (led by Options & Positioning), while RYAN wins 5–1 across the 6-pillar growth and valuation breakdown. RYAN trades at $47.86 (19.7x Forward P/E, 19.8% operating margin) versus ERIE at $275.90 (20.7x Forward P/E, 18.3% operating margin). Growth vs. Quality Trade-Off: ERIE earns the overall head-to-head edge with a stronger Unified Composite Score (47.8/100 HOLD vs. RYAN 40.7/100 SELL) and -0.51β · 38% Vol risk profile, whereas RYAN leads top-line expansion (+4.8% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.

RYAN leads the Growth & Scale pillar: RYAN posts +4.8% YoY revenue growth and +43.1% YoY earnings growth on $6.20B TTM revenue (41.1% gross margin, 19.8% operating margin), compared with ERIE at +0.3% YoY revenue growth and -0.5% YoY earnings growth on $4.12B TTM revenue (17.9% gross margin, 18.3% operating margin). On trailing 12-month operating scale, RYAN generates $6.20B in USD-normalized revenue versus $4.12B for ERIE. In operating R&D and SG&A reinvestment, RYAN deploys 21.3% of Rev ($1.32B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ERIE.

RYAN screens cheaper on headline valuation multiples. RYAN trades at 19.7x Forward P/E, 58.6x Trailing P/E, N/M PEG, and 1.9x EV/Revenue (28.5% EBITDA margin), whereas ERIE trades at 20.7x Forward P/E, 24.9x Trailing P/E, 2.67x PEG, and 3.5x EV/Revenue (13.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against RYAN (25.1% ROE) versus ERIE (23.7% ROE) capital efficiency.

In options market volatility and institutional positioning, RYAN carries 29.7% implied volatility (12th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.32β · 39% Vol realized risk). By comparison, ERIE carries 38.9% implied volatility (6th %ile, Compressed (<25th %ile)), a 0.01x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (-0.51β · 38% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.